Tumor-associated Glycans and Tregs in Immunogenicity of an Autologous Cell-based Vaccine

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Immunological Investigations

• Publication date

  2016-10-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/08820139.2016.1219865PMID 27759476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

  2016cited by this paper
• A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2

  2016cited by this paper
• Autologous melanoma cell vaccine using monocyte-derived dendritic cells (NBS20/eltrapuldencel-T).

  2016cited by this paper
• Personalized approaches to active immunotherapy in cancer.

  2016cited by this paper
• Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.

  2016cited by this paper
• CHST11 gene expression and DNA methylation in breast cancer

  2015cited by this paper
• Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy

  2015cited by this paper
• A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model

  2015cited by this paper
• High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.

  2015cited by this paper
• Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells

  2014cited by this paper
• Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen

  2013cited by this paper
• Autologous Versus Allogeneic Cell-Based Vaccines?

  2011cited by this paper
• Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells

  2011cited by this paper
• Cancer esearch oenvironment and Immunology ctive Depletion of Foxp 3 + Regulatory T Cells roves Effective Therapeutic Vaccination R inst Established Melanoma

  2010cited by this paper
• Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.

  2010cited by this paper
• Cross-Linking of GM1 Ganglioside by Galectin-1 Mediates Regulatory T Cell Activity Involving TRPC5 Channel Activation: Possible Role in Suppressing Experimental Autoimmune Encephalomyelitis1

  2009cited by this paper
• CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells

  2009cited by this paper
• Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry

  2008cited by this paper
• Regulatory T cells and immune tolerance.

  2008cited by this paper
• Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

  2007cited by this paper
• Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA?

  2006cited by this paper
• Binding of galectin-1 (gal-1) to the Thomsen–Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody

  2006cited by this paper
• Cancer metastasis: characterization and identification of the behavior of metastatic tumor cells and the cell adhesion molecules, including carbohydrates.

  2005cited by this paper
• On the Role of Cell Surface Carbohydrates and their Binding Proteins (lectins) in Tumor Metastasis

  2004cited by this paper
• Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide

  2003cited by this paper
• Increase of regulatory T cells in the peripheral blood of cancer patients.

  2003cited by this paper
• Human CD4+ CD25+ T cells regulate CD8+ T-cell activation.

  2002cited by this paper
• Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

  2002cited by this paper
• Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy?

  2002cited by this paper
• Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4

  2002cited by this paper
• Depletion of CD4+CD25+ Regulatory Cells Augments the Generation of Specific Immune T Cells in Tumor-Draining Lymph Nodes

  2002cited by this paper
• Infectious Tolerance

  2002cited by this paper
• Treatment of Kidney Cancer with Autologous Tumor Cell Vaccines of Short-Term Cell Lines Derived from Renal Cell Carcinoma

  2001cited by this paper
• Breast Cancer Progression and Expression of Blood Group-Related Tumor-Associated Antigens

  2000cited by this paper
• Metastases: the glycan connection

  2000cited by this paper
• Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice

  2000cited by this paper
• Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

  2000cited by this paper
• Tumor gangliosides inhibit the tumor-specific immune response.

  1999cited by this paper
• CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production

  1998cited by this paper
• Tn and sialyl-Tn antigens as potential prognostic markers in human ovarian carcinoma.

  1996cited by this paper
• Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

  1995cited by this paper
• Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesions.

  1994cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

  1992cited by this paper
• Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses.

  1992cited by this paper
• Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary.

  1991cited by this paper
• Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens.

  1989influential reference
• Active immunotherapy for cancer.

  1973cited by this paper

• Targeting Tn Antigen Suppresses Aberrant O‐Glycosylation‐Elicited Metastasis in Breast Cancer

  2024cites this paper
• Various Tastes of Sugar: The Potential of Glycosylation in Targeting and Modulating Human Immunity via C-Type Lectin Receptors

  2020cites this paper
• Thematic 2019 Letter from the Editor

  2019cites this paper
• ЛЕКТИНЫ В АНТИРАКОВЫХ СТРАТЕГИЯХ

  2018cites this paper
• LECTINS IN ANTI-CANCER STRATEGIES

  2018cites this paper
• Anti-α-galactoside and Anti-β-glucoside Antibodies are Partially Occupied by Either of Two Albumin-bound O-glycoproteins and Circulate as Ligand-binding Triplets

  2018cites this paper
• Letter from the Editor 2017

  2017cites this paper
• Letter from the Editor 2016

  2016cites this paper
• Treatment Induced Autophagy Associated with Tumor Dormancy and Relapse

  2016cites this paper
• Immune Regulatory Function of Tregs

  2016cites this paper